The Annals New | Pharmaco Epidemiology and Therapeutic Risk Management
home help contact us subscription past issues search current issue
 QUICK SEARCH:   [advanced]


     


The Annals of Pharmacotherapy: Vol. 33, No. 7, pp. 792-795. DOI 10.1345/aph.18298
© 1999 Harvey Whitney Books Company.
This Article
Right arrow PDF
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Articles Ahead of Print
Right arrow [Order Reprint]
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lewis,
Right arrow Articles by Dickensheets, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lewis, , JR
Right arrow Articles by Dickensheets, D.


Research Articles

Levofloxacin-induced bilateral Achilles tendonitis

Lewis JR, JG Gums, and DL Dickensheets

OBJECTIVE: To report a case of possible levofloxacin-induced bilateral Achilles tendonitis. CASE SUMMARY: An 83-year-old white woman presented to her physician with five days of hemoptysis. She was diagnosed with right lower-lobe pneumonia based on chest X-ray, and levofloxacin 500 mg/d po for 10 days was prescribed. Three days into treatment she began having a variety of adverse effects, including severe nausea, constipation, stomach cramps, and dizziness. Signs of tendonitis began three days after treatment and peaked four days after completion of therapy. Two weeks later, she was treated by her podiatrist with an ankle immobilizer and rest. At her three-week follow-up, she had marked improvement in her pain and bruising; however, her symptoms had not completely resolved. DISCUSSION: Tendonitis and tendon rupture are rare adverse effects of fluoroquinolone antibiotics; there are no reports in the literature of levofloxacin-induced tendonitis. As newer fluoroquinolones become available, the postmarketing studies will become increasingly important to capture the data on rare but serious adverse effects not discovered in the premarketing trials. CONCLUSIONS: To our knowledge, this is the first reported case of tendonitis caused by levofloxacin reported in the literature. Reports have been made, however, to the manufacturer via postmarketing surveillance. As more people are treated with newer fluoroquinolones, the clinical incidence of tendon rupture with these agents may become clearer.


This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
F. Pouzaud, K. Bernard-Beaubois, M. Thevenin, J.-M. Warnet, G. Hayem, and P. Rat
In Vitro Discrimination of Fluoroquinolones Toxicity on Tendon Cells: Involvement of Oxidative Stress
J. Pharmacol. Exp. Ther., January 1, 2004; 308(1): 394 - 402.
[Abstract] [Full Text] [PDF]


Home page
The Annals of PharmacotherapyHome page
A S. Mathis, V. Chan, M. Gryszkiewicz, R. T Adamson, and G. S Friedman
Levofloxacin-Associated Achilles Tendon Rupture
Ann. Pharmacother., July 1, 2003; 37(7): 1014 - 1017.
[Abstract] [Full Text] [PDF]


Home page
J Antimicrob ChemotherHome page
L. J. Haddow, M. Chandra Sekhar, V. Hajela, and G. Gopal Rao
Spontaneous Achilles tendon rupture in patients treated with levofloxacin
J. Antimicrob. Chemother., March 1, 2003; 51(3): 747 - 748.
[Full Text] [PDF]




homecopy help contact us subscription past issues search current issue
Copyright © 1999 by Harvey Whitney Books Company.